Viral haemorrhagic fevers with emphasis on Ebola virus disease and oro-dental healthcare

Oral Diseases

Volumn 21, Issue 1, 2015, Pages 1-6

  Samaranayake, Lakshman ^a   Scully, Crispian ^a   Nair, Raj G ^a   Petti, Stefano ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; ANIMAL; DENTAL PROCEDURE; DISEASE TRANSMISSION; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HEMORRHAGIC FEVERS, VIRAL; HUMAN; PREVENTION AND CONTROL; TRANSMISSION;

ANIMALS; DENTAL CARE; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HEMORRHAGIC FEVERS, VIRAL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL;

EID: 84919340689     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12298     Document Type: Editorial

References (27)

1. Anonymous (1978a). Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 56: 247-270.
2. Anonymous (1978b). Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56: 271-293.
3. Ansari AA (2014). Clinical features and pathobiology of Ebolavirus infection. J Autoimmun 55: 1-9.
4. Baron RC, McCormick JB, Zubeir OA (1983). Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61: 997-1003.
5. Bonnet MJ, Akamituna P, Mazaya A (1998). Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 4: 508-510.
6. Bwaka MA, Bonnet MJ, Calain P et al (1999). Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179(Suppl 1): S1-S7.
7. Centers for Disease Control and Prevention (CDC) (2014a). Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Virus Disease in U.S. Hospitals. Available at: http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html [accessed on 12 October 2014].
8. Centers for Disease Control and Prevention (CDC) (2014b). Texas Reports Positive Test for Ebola in a Health Care Worker. Available at: http://www.cdc.gov/media/releases/2014/s1012-texas-health-care-worker.html [accessed 13 October 2014].
9. Ebihara H, Rockx B, Marzi A et al (2011). Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis 204: S991-S999.
10. Feldmann H, Geisbert TW (2011). Ebola haemorrhagic fever. Lancet 377: 849-862.
11. Formenty P, Leroy EM, Epelboin A et al (2006). Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 42: 1521-1526.
12. Gatherer D (2014). The 2014 Ebola virus disease outbreak in West Africa. J Gen Virol 95(Pt 8): 1619-1624.
13. Hwang ES (2014). Preparedness for Prevention of Ebola Virus Disease. J Korean Med Sci 29: 1185.
14. Johnson E, Jaax N, White J, Jahrling P (1995). Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 76: 227-236.
15. Kanapathipillai R, Restrepo AM, Fast P et al (2014). Ebola vaccine - an urgent international priority. N Engl J Med doi: 10.1056/NEJMp1412166 [Epub ahead of print].
16. Lefebvre A, Fiet C, Belpois-Duchamp C, Tiv M, Astruc K, Aho Glélé LS (2014). Case fatality rates of Ebola virus diseases: a meta-analysis of World Health Organization data. Med Mal Infect 44: 412-416.
17. Leroy EM, Baize S, Volchkov VE et al (2000). Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355: 2210-2215.
18. Li YH, Chen SP (2014). Evolutionary history of Ebola virus. Epidemiol Infect 142: 1138-1145.
19. Mupere E, Kaducu OF, Yoti Z (2001). Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci 1: 60-65.
20. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe-Tamfum JJ, Colebunders R (1999). Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1): S8-S10.
21. Roddy P, Howard N, Van Kerkhove MD et al (2012). Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One 7(12): e52986. doi:10.1371/journal.pone.0052986.
22. Samaranayake LP (2014). The Ebola virus epidemic: a concern for dentistry? Dental Tribune News Asia Pacific. Aug 15: 8-10.
23. Samaranayake LP, Peiris JS, Scully C (1996). Ebola virus infection: an overview. Br Dent J 180: 264-266.
24. Sureau PH (1989). Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis 11(Suppl 4): S790-S793.
25. Viral Hemorrhagic Fevers (Special Pathogens Branch, CDC) http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm
26. WHO Ebola Response Team (2014). Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. N Engl J Med [Epub ahead of print] http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm
27. World Health Organization (WHO) (2014). Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola. Geneva: WHO.